Arteritis, Giant Cell
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO (NCT03841734) | Centre Hospitalier Universitaire de Nice | 2020-02-04 |
| Baricitinib in Relapsing Giant Cell Arteritis (NCT03026504) | Matthew J Koster | 2017-03-09 |
Track Arteritis, Giant Cell automatically
Every clearance here is in the API, with alerts when new ones post.